The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective
- PMID: 39345911
- PMCID: PMC11439355
- DOI: 10.2147/IJN.S477835
The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective
Abstract
The endocrine system regulates many biological systems, and disruptions may result in disorders, such as diabetes, thyroid dysfunction, Cushing's syndrome, and obesity. The total incidence of endocrine illnesses was found to be 47.4%, excluding type 2 diabetes mellitus, with a significant frequency of newly diagnosed endocrine disorders. Nanotechnology manipulates particles at the atomic and molecular levels, opening up new paths for studying disease etiology and therapeutic alternatives. The goal of using nanomaterials in the treatment of endocrine illnesses is to create endogenous nano-biosensors that can detect even modest changes in hormone levels and react spontaneously to restore normal function. The size and surface characteristics of nanoparticles enhances the sensitivity in nano-sensors and are functionalized for targeted drug delivery. Nano-sized carriers composed of lipids, polymers, carbon, or metals have been shown to work much better than standard drug delivery methods. Nanoparticles (NPs) offer various advantages over current methods for diagnosing and treating endocrine disorders, acting as hydrogels for insulin delivery and wound healing. Incorporating selenium NPs into inorganic nanoparticles enhances their bioactivity and targeted delivery. Gold NPs show a promising precise insulin delivery. Mesoporous silica NPs maintain glycemic level effectively and lipid and polymeric NPs protect drugs from degradation in the gastrointestinal tract. Carbon nanotubes (CNTs) have become popular in thyroid surgeries. These characteristics make nanoparticles valuable for developing effective diagnostic and therapeutic systems. NP-based medicines have been thoroughly researched in order to identify the beginning point for the creation of theranostics, which may function in two ways: as imaging agents or therapeutics. The study posits that nanotechnology bridges diagnostics and therapies, potentially revolutionizing endocrine disorder treatments. This review delves into nanotechnology techniques, emphasizing their applications in diagnosing and treating diabetes mellitus.
Keywords: diabetes; endocrine disorders; nanomedicines; theranostics; thyroid dysfunction.
© 2024 Yan et al.
Conflict of interest statement
All the authors declare that they have no competing interests in this work.
Figures



Similar articles
-
Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices.Biomed Pharmacother. 2024 Jul;176:116840. doi: 10.1016/j.biopha.2024.116840. Epub 2024 May 30. Biomed Pharmacother. 2024. PMID: 38820975 Review.
-
Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.Crit Rev Ther Drug Carrier Syst. 2014;31(1):1-47. doi: 10.1615/critrevtherdrugcarriersyst.2013007914. Crit Rev Ther Drug Carrier Syst. 2014. PMID: 24579766 Review.
-
A review of RNA nanoparticles for drug/gene/protein delivery in advanced therapies: Current state and future prospects.Int J Biol Macromol. 2025 Mar;295:139532. doi: 10.1016/j.ijbiomac.2025.139532. Epub 2025 Jan 5. Int J Biol Macromol. 2025. PMID: 39765293 Review.
-
Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.Nanomedicine (Lond). 2017 Feb;12(4):357-385. doi: 10.2217/nnm-2016-0305. Epub 2017 Jan 12. Nanomedicine (Lond). 2017. PMID: 28078952 Review.
-
Diabetology and Nanotechnology: A Compelling Combination.Recent Pat Nanotechnol. 2025;19(1):4-16. doi: 10.2174/0118722105253055231016155618. Recent Pat Nanotechnol. 2025. PMID: 37937555 Review.
Cited by
-
Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery.Pharmaceutics. 2024 Dec 9;16(12):1572. doi: 10.3390/pharmaceutics16121572. Pharmaceutics. 2024. PMID: 39771551 Free PMC article. Review.
-
Polymeric Nanomedicines in Diabetic Wound Healing: Applications and Future Perspectives.Int J Nanomedicine. 2025 May 22;20:6423-6446. doi: 10.2147/IJN.S514000. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40420911 Free PMC article. Review.
-
Editorial: Omics in endocrinology: from biomarker discovery to targeting therapeutic strategies.Front Mol Biosci. 2025 Feb 13;12:1567250. doi: 10.3389/fmolb.2025.1567250. eCollection 2025. Front Mol Biosci. 2025. PMID: 40017631 Free PMC article. No abstract available.
-
The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research.Biomolecules. 2025 May 1;15(5):653. doi: 10.3390/biom15050653. Biomolecules. 2025. PMID: 40427546 Free PMC article. Review.
References
-
- Al-Khater KM, Al-Suhaimi EA. Application of Nanomaterials in Treatment of Endocrine Diseases. Applic Nanomat Human Health. 2020;191–210.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous